Congressional Report Highlights FDA’s Role in Emerging Hemp Markets

Congressional Report Highlights FDA’s Role in Emerging Hemp Markets

A

Membership required to view content.
issued Friday by the Congressional Research Service (CRS) provides a broad overview of the development of the hemp industry, specifically floral hemp and its associated extracts like CBD. 

The report highlights the role of the FDA in the emerging hemp industry, and its failure to create a regulatory pathway for CBD.  It noted that after years of review by a high-level internal working group, the FDA announced in January it would work with Congress to create a new regulatory pathway for CBD. 

Membership is required to view the rest of this post.
Click here to learn more and sign up for a free 7-day trial!

Blog

12.24.2024

Animal fats, oils markets quiet amid Christmas holiday

Animal fats, oils markets quiet amid Christmas holiday

The US animal fats and oils markets remained steady on Tuesday December 24, amid limited trading due to the Christmas holidays.

Market sources expected activity to remain subdued...

12.24.2024

US November broiler, turkey slaughter down year on year

US November broiler, turkey slaughter down year on year

US animal protein prices were steady on Tuesday December 24, with limited volumes reported to have been traded. With the proximity of the end-of-year holidays, most market participants are...

12.24.2024

US weekly soybean, wheat export inspections rise, corn falls

US weekly soybean, wheat export inspections rise, corn falls

Weekly export inspections
Export inspections of US grains showed a decline for corn but an increase for soybean and wheat in the week to December 19, according to data...

Latest Tweets